English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Aug 3, 2026

Biologics drive expansion of sterile fill-finish and prefilled syringe capacity at CMOs and CDMOs
+ Pharmaceuticals
Patient Daily | Aug 3, 2026

Texas A&M researchers link polyethylene microplastics to increased risk of fatty liver disease
+ Pharmaceuticals
Patient Daily | Aug 3, 2026

First consensus guidelines address GLP-1 medication use before, during, and after pregnancy
+ Pharmaceuticals
Patient Daily | Aug 3, 2026

Review examines effects of amino acid restriction on aging and metabolism
+ Pharmaceuticals
Patient Daily | Aug 3, 2026

Start-ups selected for the 70th International Congress of Hearing Care Professionals
+ Pharmaceuticals
Patient Daily | Aug 3, 2026

LJI study links lung immune cell genes to autoimmune disease risk
+ Pharmaceuticals
Patient Daily | Aug 3, 2026

Novo Nordisk’s ziltivekimab fails Phase 3 trial, impacting inflammation drug developers
+ Pharmaceuticals
Patient Daily | Aug 3, 2026

NICE criteria miss most younger women at risk for breast cancer, study finds

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes